jamel
ortoleva
md
tuft
medic
center
depart
anesthesiolog
periop
medicin
th
floor
ziskind
build
washington
street
boston
email
jortoleva
tuftsmedicalcenterorg
author
report
conflict
interest
relev
work
novel
coronaviru
infect
patient
nearli
everi
countri
result
death
forti
thousand
peopl
worldwid
predomin
caus
critic
ill
death
coronaviru
patient
acut
respiratori
distress
syndrom
ard
anoth
import
caus
frequent
present
ard
cytokin
storm
result
vasodilatori
shock
multiorgan
dysfunct
hyperinflamm
associ
cytokin
storm
similar
found
secondari
haemophagocyt
lymphohistiocytosi
hlh
elev
level
molecul
includ
limit
interleukin
il
found
patient
suffer
hyperinflammatori
respons
immun
modul
cytokin
storm
inhibitor
sarilumab
tocilizumab
approach
gain
interest
activ
area
investig
anesthesiologist
uniqu
posit
blend
uniqu
skill
set
knowledg
mechan
ventil
hemodynam
manag
procedur
expertis
pharmacolog
treat
critic
ill
patient
popular
agent
recent
resurg
ketamin
phencyclidin
dissoci
amnest
act
antagonist
nmethyldaspart
receptor
use
ketamin
gain
signific
interest
sedat
anesthesia
myriad
set
well
known
ketamin
increas
blood
pressur
heart
rate
releas
endogen
catecholamin
caus
bronchodil
potent
analges
sed
minim
effect
respiratori
statu
would
excit
studi
ketamin
part
sedat
regimen
doubl
blindrandom
fashion
patient
respiratori
failur
due
antiinflammatori
effect
confer
reduc
risk
cytokin
storm
neg
effect
inflamm
may
morbid
mortal
benefit
new
use
costeffect
safe
readili
avail
medic
could
revolution
effort
treat
global
pandem
